LD-2 disclosure · 4th Quarter - Report
ACADIA PHARMACEUTICALS
Client
- Location
- California · United States of America
Registrant
- Description
- Biopharmaceutical company
- Location
- San Diego, California, United States of America
Lobbying activities
2 issuesHealth Issues
Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S. 1375); Orphan Cures Act (HR 5539); Issues related to rare disease research incentives; National Plan to End Parkinson's Act (HR 2365 / S. 1064); Protect Rare Act (HR 6094).
Lobbyistsmr MICHAEL MATTOON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to access to medicines for Parkinson's disease patients; HR 4096 - Issues Related to Antipsychotic use in Medicaid; HR 5539 - Orphan Cures Act; HR 2365 / S. 1064 - National Plan to End Parkinson's Act; HR 6094 - Protect Rare Act.
Lobbyistsmr MICHAEL MATTOON
TargetedSENATE · HOUSE OF REPRESENTATIVES